APA (7th ed.) Citation

Tanimura, K., Takeda, T., Kataoka, N., Yoshimura, A., Nakanishi, K., Yamanaka, Y., . . . Kurata, T. (2023). First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study. Cancers, 15(20), 4988. https://doi.org/10.3390/cancers15204988

Chicago Style (17th ed.) Citation

Tanimura, Keiko, et al. "First-Line Chemoimmunotherapy Versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study." Cancers 15, no. 20 (2023): 4988. https://doi.org/10.3390/cancers15204988.

MLA (9th ed.) Citation

Tanimura, Keiko, et al. "First-Line Chemoimmunotherapy Versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study." Cancers, vol. 15, no. 20, 2023, p. 4988, https://doi.org/10.3390/cancers15204988.